Willem J.M. Dewilde - Concepedia

Author

Willem J.M. Dewilde

Also Known As

Thomas Bergmeijer, W. J. M Dewilde, W. J. M. Dewilde, W.J. Dewilde, Willem J Dewilde, Willem J M Dewilde, Willem J. Dewilde, Willem J. M. Dewilde, Willem J.M. Dewilde, Willem JM Dewilde

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Meander Medisch Centrum St. Antonius Ziekenhuis OLVG Amphia Ziekenhuis Isala

About

Willem J.M. Dewilde is an author at Meander Medisch Centrum specializing in cardiovascular disease, cardiology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	1.8K
2	Public Health	2	2	108
3	Epidemiology	2	2	108
4	Cardiovascular Genetics	2	2	108
5	Emergency Medicine	1	1	1.7K

Willem J.M. Dewilde

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Willem J.M. Dewilde, Tom Oirbans, Freek W.A. Verheugt, The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseOral Anticoagulant TherapyCoronary Artery Disease	2013	1.7K
A Genotype-Guided Strategy for Oral P2Y <sub>12</sub> Inhibitors in Primary PCI Daniel M.F. Claassens, Gerrit J.A. Vos, Thomas O. Bergmeijer, New England Journal of Medicine	2019	597
CYP2C19 genotype–guided antiplatelet therapy in ST-segment elevation myocardial infarction patients—Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study Thomas O. Bergmeijer, Paul W.A. Janssen, Jurjan C. Schipper, American Heart Journal ThrombosisPercutaneous Coronary InterventionAntiplatelet TherapyCardiovascular DiseasePrimary Pci	2014	81
Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial Willem J.M. Dewilde, Paul W.A. Janssen, Johannes C. Kelder, EuroIntervention	2015	50
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial Daniel M.F. Claassens, Pim W. M. van Dorst, Gerrit J.A. Vos, American Journal of Cardiovascular Drugs EpidemiologyCardiovascular DiseasePopular Genetics TrialClinical TrialsPharmacogenomics	2021	27
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype Daniel M.F. Claassens, Thomas O. Bergmeijer, Gerrit J.A. Vos, Circulation Cardiovascular Interventions	2021	26
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta‐analysis Andrea Saglietto, Fabrizio D’Ascenzo, Daniele Errigo, Catheterization and Cardiovascular Interventions	2020	10

Page 1